Registration of APIs CMC information required for an IND
IND and NDA support Drug master files (DMF) filing
Synonyms/Alias | Deltorphin;119975-64-3;Dermenkephalin;Deltorphin A;L-alpha-Asparagine, L-tyrosyl-D-methionyl-L-phenylalanyl-L-histidyl-L-leucyl-L-methionyl-;Tyr-met-phe-his-leu-met-asp-NH2;CHEMBL20775;CHEBI:81455;DTXSID60152630;Tyrosyl-methionyl-phenylalanyl-histidyl-leucyl-methionyl-aspartamide;(3S)-4-amino-3-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-phenylpropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-oxobutanoic acid;(5R,8S,11S,14S,17S,20S)-11-((1H-imidazol-4-yl)methyl)-5-((S)-2-amino-3-(4-hydroxyphenyl)propanamido)-8-benzyl-20-carbamoyl-14-isobutyl-17-(2-(methylthio)ethyl)-6,9,12,15,18-pentaoxo-2-thia-7,10,13,16,19-pentaazadocosan-22-oic acid;L-alpha-Asparagine, N2-(N-(N-(N-(N-(N-L-tyrosyl-D-methionyl)-L-phenylalanyl)-L-histidyl)-L-leucyl)-L-methionyl)-;H-Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2;DTXCID3075121;GLXC-25917;3-(2-{2-[2-(2-{2-[2-Amino-3-(4-hydroxy-phenyl)-propionylamino]-4-methylsulfanyl-butyrylamino}-3-phenyl-propionylamino)-3-(3H-imidazol-4-yl)-propionylamino]-4-methyl-pentanoylamino}-4-methylsulfanyl-butyrylamino)-succinamic acid;BDBM50000518;AKOS037647558;AKOS040744531;AS-74086;DA-72655;H-Tyr-(D)Met-Phe-His-Leu-Met-Asp-NH2;HY-129271;CS-0104599;C18010;G77949;Q5254878;3-(2-{2-[2-(2-{2-[2-Amino-3-(4-hydroxy-phenyl)-propionylamino]-4-methylsulfanyl-butyrylamino}-3-phenyl-propionylamino)-3-(3H-imidazol-4-yl)-propionylamino]-4-methyl-pentanoylamino}-4-methylsulfanyl-butyrylamino)-succinamic acid (deltorphin A); |
M.F/Formula | C44H62N10O10S2 |
M.W/Mr. | 955.2 |
Sequence | One Letter Code:YMFHLMD Three Letter Code:H-Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2 |
InChI | InChI=1S/C44H62N10O10S2/c1-25(2)18-34(42(62)50-32(15-17-66-4)40(60)51-33(38(46)58)22-37(56)57)52-44(64)36(21-28-23-47-24-48-28)54-43(63)35(20-26-8-6-5-7-9-26)53-41(61)31(14-16-65-3)49-39(59)30(45)19-27-10-12-29(55)13-11-27/h5-13,23-25,30-36,55H,14-22,45H2,1-4H3,(H2,46,58)(H,47,48)(H,49,59)(H,50,62)(H,51,60)(H,52,64)(H,53,61)(H,54,63)(H,56,57)/t30-,31+,32-,33-,34-,35-,36-/m0/s1 |
InChI Key | BHSURCCZOBVHJJ-NWOHMYAQSA-N |
2. High fat diet and GLP-1 drugs induce pancreatic injury in mice
5. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us. We will endeavor to provide highly satisfying products and services.